Market Tracker

10/24 6:05pm ET

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.36
Data as of Oct 24
 -0.04 / -2.86%
Today’s Change
1.11
Today|||52-Week Range
2.26
-34.30%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close1.40
Today’s open1.41
Day’s range1.36 - 1.41
Volume267,720
Average volume (3 months)599,245
Market cap$204.9M
Dividend yield--
Data as of 4:03pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)-18.72%
Earnings growth (this year)+22.14%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,335.94%
P/E ratioNM
Price/Sales223.01
Price/Book--

Competitors

 Today’s
change
Today’s
% change
IDRAIdera Pharmaceutical...-0.03-1.20%
AMPEAmpio Pharmaceutical...+0.13+3.43%
ATNMActinium Pharmaceuti...-0.02-0.29%
NNVCNanoViricides Inc-0.04-1.16%
Data as of 4:00pm ET, 10/24/2014

Financials

Next reporting dateOctober 29, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$1.1M
Annual profit (last year)-$42.7M
Net profit margin-3,776.61%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Rick Gonzalez
President &
Chief Business Officer
Thomas H. Tulip
Corporate headquarters
Dublin, Ohio

Forecasts